Enzo Biochem Inc

CIK 316253 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Enzo Biochem Inc.

Recent SEC filings

FiledFormAccession number
Nov 14, 2025SCHEDULE 13G/A0000935836-25-000691
Aug 29, 2025EFFECT9999999995-25-002782
Aug 29, 2025EFFECT9999999995-25-002783
Aug 22, 2025SCHEDULE 13D/A0000921895-25-002365
Aug 20, 2025S-8 POS0001213900-25-078765
Aug 20, 202540001213900-25-078741
Aug 20, 202540001213900-25-078744
Aug 20, 2025S-8 POS0001213900-25-078763
Aug 20, 202540001213900-25-078737
Aug 20, 202540001213900-25-078740
Aug 20, 2025S-8 POS0001213900-25-078759
Aug 20, 2025S-8 POS0001213900-25-078760
Aug 20, 20258-K0001213900-25-078736
Aug 20, 2025S-8 POS0001213900-25-078761
Aug 20, 2025POS AM0001213900-25-078748
Aug 20, 202515-12G0001213900-25-078769
Aug 20, 2025S-8 POS0001213900-25-078757
Aug 20, 202540001213900-25-078738
Aug 20, 2025S-8 POS0001213900-25-078766
Aug 20, 2025S-8 POS0001213900-25-078762
Aug 20, 2025POS AM0001213900-25-078746
Aug 20, 2025S-8 POS0001213900-25-078756
Aug 20, 2025S-8 POS0001213900-25-078754
Aug 19, 20258-K0001213900-25-078465
Aug 8, 2025DEFA14A0001213900-25-073181